SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030379
Filing Date
2019-08-08
Accepted
2019-08-08 06:31:01
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q krtx-10q_20190630.htm 10-Q 2658477
2 EX-31.1 krtx-ex311_11.htm EX-31.1 9625
3 EX-31.2 krtx-ex312_10.htm EX-31.2 9740
4 EX-32.1 krtx-ex321_9.htm EX-32.1 8164
  Complete submission text file 0001564590-19-030379.txt   7708488

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT krtx-20190630.xml EX-101.INS 1466197
6 XBRL TAXONOMY EXTENSION SCHEMA krtx-20190630.xsd EX-101.SCH 48932
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krtx-20190630_cal.xml EX-101.CAL 47284
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krtx-20190630_def.xml EX-101.DEF 210401
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krtx-20190630_lab.xml EX-101.LAB 410952
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krtx-20190630_pre.xml EX-101.PRE 331593
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38958 | Film No.: 191007360
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences